Ozempic can change how your digestive system works
Total loss by week 24 typically ranges from 12-16%
The STEP 1 trial showed average weight loss of 14.9% over 68 weeks
The FDA cannot verify the quality, safety, or effectiveness of these non-FDA-approved compounded GLP-1 products Entities engaged in mass marketing should be on notice. FDA Press Announcement In regulatory language, the agency also made clear that compounded products cannot be marketed as generic, clinically proven, or equivalent to approved drugs
If TRIUMPH-1 or TRIUMPH-2 reveal a new safety concern not seen in smaller trials, the FDA could require additional studies
Vomiting after meals, persistent abdominal discomfort, or difficulty eating normal portions may appear